Int’l Health Group Advocates Using Experimental Drugs on Transgender Children

According to new guidelines released yesterday, a leading international health organization is encouraging children under 16 who identify as transgender to undergo highly experimental hormonal therapies — such as puberty-blocking treatment and cross-sex hormones — aimed at making their bodies appear to be that of the other sex, despite the possibly damaging side effects of these therapies. The new clinical guidelines were developed by an international medical team and published by the Endocrine Society. Because of this organization’s vast membership base, its recommendations are expected to exert widespread influence on the type of medical care given to children around the